glutathione colon cancer Reductase Expression and Its Prognostic Significance in Glutathione S-transferase M1-null genotype as
Glutathione S transferase M1 null genotype as risk factor for SOS in oxaliplatin treated patients with metastatic colorectal cancer British Journal of Cancer Glutathione and UDP HexNAc as marker metabolites enriched in colon Download Scientific Diagram Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum Based Drugs Chemical Reviews AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancer ScienceDirect BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis ScienceDirect
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




